Brighthouse Financial, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Brighthouse Financial, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.77B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $4.72B | Feb 24, 2026 |
| FY2023 | Dec 31, 2023 | $1.40B | Feb 22, 2024 |
| FY2023 | Sep 30, 2023 | $1.17B | Feb 22, 2024 |
| FY2023 | Jun 30, 2023 | $263.00M | Feb 22, 2024 |
| FY2023 | Mar 31, 2023 | $1.28B | Feb 22, 2024 |
| FY2023 | Dec 31, 2022 | ($127.00M) | Feb 22, 2024 |
| FY2023 | Sep 30, 2022 | $1.12B | Feb 22, 2024 |
| FY2023 | Jun 30, 2022 | $3.87B | Feb 22, 2024 |
| FY2023 | Mar 31, 2022 | $2.01B | Feb 22, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $433.00M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $388.00M | Feb 24, 2026 |
| FY2023 | Dec 31, 2023 | ($917.00M) | Feb 22, 2024 |
| FY2023 | Sep 30, 2023 | $479.00M | Feb 22, 2024 |
| FY2023 | Jun 30, 2023 | ($175.00M) | Feb 22, 2024 |
| FY2023 | Mar 31, 2023 | ($499.00M) | Feb 22, 2024 |
| FY2023 | Dec 31, 2022 | $136.00M | Feb 22, 2024 |
| FY2023 | Sep 30, 2022 | $413.00M | Feb 22, 2024 |
| FY2023 | Jun 30, 2022 | $1.75B | Feb 22, 2024 |
| FY2023 | Mar 31, 2022 | $1.59B | Feb 22, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $259.00M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($290.00M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | ($137.00M) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | ($1.23B) | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $641.00M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $888.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.83B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $3.06B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $3.40B | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $3.74B | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $241.80B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $238.54B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $236.34B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $224.85B | Feb 22, 2024 |
| FY2023 | Dec 31, 2021 | $262.26B | Feb 22, 2024 |
| FY2021 | Dec 31, 2020 | $247.87B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $227.26B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $206.29B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $224.19B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $221.93B | Mar 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $234.97B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $233.51B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $231.33B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $219.25B | Feb 22, 2024 |
| FY2023 | Dec 31, 2021 | $253.81B | Feb 22, 2024 |
| FY2021 | Dec 31, 2020 | $229.78B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $211.02B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $191.81B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $209.61B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $207.07B | Mar 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.77B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $4.96B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $4.94B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $5.53B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $16.14B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $18.02B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $16.17B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $14.42B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $14.52B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $14.86B | Mar 16, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($686.00M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($1.12B) | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | ($1.51B) | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | ($395.00M) | Feb 22, 2024 |
| FY2023 | Dec 31, 2021 | ($4.27B) | Feb 22, 2024 |
| FY2021 | Dec 31, 2020 | ($534.00M) | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $585.00M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $1.35B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $406.00M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $0 | Mar 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $4.47B | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $4.11B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.88B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $4.15B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $1.86B | Feb 26, 2019 |
| FY2018 | Dec 31, 2016 | $5.23B | Feb 26, 2019 |
| FY2018 | Dec 31, 2015 | $1.57B | Feb 26, 2019 |
| FY2017 | Dec 31, 2014 | $1.60B | Mar 16, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.16B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $3.16B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $3.16B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $3.16B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $3.16B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $3.44B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $4.37B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $3.96B | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $3.61B | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $1.91B | Mar 16, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 24, 2026 |
| FY2023 | Dec 31, 2023 | (14) | Feb 22, 2024 |
| FY2023 | Sep 30, 2023 | 6 | Feb 22, 2024 |
| FY2023 | Jun 30, 2023 | (3) | Feb 22, 2024 |
| FY2023 | Mar 31, 2023 | (7) | Feb 22, 2024 |
| FY2023 | Dec 31, 2022 | 1 | Feb 22, 2024 |
| FY2023 | Sep 30, 2022 | 5 | Feb 22, 2024 |
| FY2023 | Jun 30, 2022 | 23 | Feb 22, 2024 |
| FY2023 | Mar 31, 2022 | 20 | Feb 22, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Feb 24, 2026 |
| FY2023 | Dec 31, 2023 | (14) | Feb 22, 2024 |
| FY2023 | Sep 30, 2023 | 6 | Feb 22, 2024 |
| FY2023 | Jun 30, 2023 | (3) | Feb 22, 2024 |
| FY2023 | Mar 31, 2023 | (7) | Feb 22, 2024 |
| FY2023 | Dec 31, 2022 | 1 | Feb 22, 2024 |
| FY2023 | Sep 30, 2022 | 5 | Feb 22, 2024 |
| FY2023 | Jun 30, 2022 | 22 | Feb 22, 2024 |
| FY2023 | Mar 31, 2022 | 20 | Feb 22, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 57.17M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 58.63M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 63.50M | Feb 24, 2026 |
| FY2025 | Dec 31, 2022 | 68.28M | Feb 24, 2026 |
| FY2024 | Dec 31, 2021 | 77.87M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | 88.21M | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | 106.03M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | 117.53M | Feb 24, 2022 |
| FY2020 | Dec 31, 2017 | 119.77M | Feb 24, 2021 |
| FY2018 | Aug 4, 2017 | 119.77M | Feb 26, 2019 |